نتائج البحث 1071-1080 من 4980 لعملية البحث عن Blood factor II
... two- and five-year followup and at skeletal maturity. ... Human Blood and Tissues Repository for Neuroscience Research ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه ...
Although some fetuses present with arrhythmias easily recognized as LQTS (torsade des pointes (TdP) and/or 2 ... Thus, to determine if quantitative blood volume ...
Randomized Phase II/III Trial of Adjuvant ... In this study, some of the patient's T cells will be removed from their blood. ... Factors. Rochester, Minn ...
We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests ...
A Study to Collect Clinical Data, Blood Samples, and Tissue Specimens from Patients with Metastatic Breast Cancer ... (ii) to collect information about patients ...
... II-III meningioma that has come back. Monoclonal ... Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ...
This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance ...
The purpose of this study is to look at the blood's clotting response in people who have suffered a traumatic injury and compare it with non-injured people.
The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood ... 2 or 3 meningioma as measured by 6-month PFS rate.
... blood samples for future DNA/RNA sequencing , and to collect patient urine samples for future prostate cancer related biomarker detection and DNA/RNA sequencing ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.